&lt;Techniclone International>
said it has entered a joint venture with Seeds of Tomorrow to
apply its electrogene process to developing new or improved
plant varieties.
    The process, which has a patent pending, was developed
originally for use in human cancer.
    The joint venture will address genetic transformation of
cotton and tomatoes.
    The company said it is also negotiating such ventures with
several other plant companies.
 Reuter
&#3;